When MLH1 and PMS2 are absent by IHC, the next step is analysis of BRAF by either PCR or IHC [50, 51, 54, 55] to help determine if the patient has a sporadic tumor or should be further evaluated for LS. This evidence concerns the gene MLH1 and neoplasm.